
The episode explores the relationship between wealth and weight loss, featuring discussions on GLP-1 drugs and their economic implications for women.
In the western world, richer people tend to be thinner – especially women. But does wealth make people thin, or does being thin make them wealthy? And could the rise of weight-loss drugs such as Mounjaro and Wegovy give people – especially women – greater control over their economic outcomes? Soumaya speaks to Harvard professor Rebecca Diamond, the author of a new working paper that finds female users of GLP-1 drugs are more likely to find jobs and romantic partners. Soumaya also speaks to FT consumer editor (and GLP-1 user) Claer Barrett to discuss the drugs’ effects on consumer habits – and the economy at large. Subscribe to Soumaya's show on Apple , Spotify , Pocket Casts or wherever you listen. Further reading: The economics of women’s weight Does the weight-loss revolution show up in the data? The challenges of a weight-loss economy Presented by Soumaya Keynes. Produced by Mischa Frankl-Duval. Original music and sound design by Breen Turner. Andrew Georgiades is the broadcast engineer. Manuela Saragosa is the executive producer. Flo Phillips if the FT's head of audio. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
Host: Soumaya Keynes
Guests: Rebecca Diamond, Claer Barrett
Organizations: Harvard, Financial Times
Products: Mounjaro, Wegovy
Explore listener stats, chart rankings, contacts and more on the The Economics Show podcast page.